CompletedNot Applicable

ERCP in Idiopathic Recurrent Acute Pancreatitis

United States89 participantsStarted 1997-09

Plain-language summary

The therapeutic impact of ERCP with sphincterotomy in the management of patients with idiopathic recurrent acute pancreatitis (RAP) needs further study. The investigators conducted a single center, feasibility, randomized trial to determine 1) the role of pancreatic manometry in predicting future episodes of RAP and 2) differences in the efficacy of no, biliary (BES) or pancreatobiliary (dual) endoscopic sphincterotomy (DES).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Idiopathic recurrent acute pancreatitis, defined as two or more episodes requiring hospitalization * ERCP with SOM planned Exclusion Criteria: * Chronic pancreatitis * Pancreas divisum * Alternate etiology identified (e.g., CBD stone, IPMN) * Inability to perform pancreatic manometry * Pregnancy, age \< 18, incarceration * Inability to provide informed consent

What they're measuring

Recurrent acute pancreatitis

Timeframe: 120 months

Trial details

NCT IDNCT01583517

SponsorIndiana University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2012-04

View on ClinicalTrials.gov More Recurrent Acute Pancreatitis trials